Search clinical trials for: FP

Total 110 results

FHI 360
Ministry of Health, Uganda

Completed

Community-based Delivery of Integrated Family Planning/HIV Testing and Counseling Services in Uganda

HIV Testing and Counseling

Uganda
Immune Targeting Systems Ltd

Completed

Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults

Influenza A
Foresee Pharmaceuticals Co., Ltd.

Completed

The Effect of FP-025, a MMP-12 Inhibitor, on Allergen-induced Airway Responses and Airway Inflammation in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma

Asthma, COPD

Netherlands
CSL Behring

Completed

A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

Hemophilia B

United States, Japan, Israel, Austria, Bulgaria, France, Germany, Italy, Russian Federation, Spain
University of California, San Francisco
Population Services International

Completed

Improving Person-Centered Care for Family Planning in India (SPARQ_FPI)

Family Planning

India
Fervent Pharmaceuticals
ICON plc

Completed

FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms

Vasomotor Symptoms | Menopause

United States
Five Prime Therapeutics, Inc.
Parexel

Completed

Safety Study of FP-1039 To Treat Cancer

Advanced Cancer

United States
CSL Behring

Completed

A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B

Hemophilia B

Germany, Australia, Italy, Israel, Czech Republic, Spain, France, Canada, Austria, Russian Federation
Foresee Pharmaceuticals Co., Ltd.

Recruiting

A Dose Escalation Study of FP-045 in Patients With Fanconi Anemia

Fanconi Anemia

United States
CSL Behring

Completed

A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

Hemophilia B

United States, Australia, Japan, France, Philippines, Spain, Czechia, Israel, Canada, Germany, Austria, Bulgaria, Italy, Malaysia, South Africa
Five Prime Therapeutics, Inc.
Worldwide Clinical Trials

Withdrawn

Study of FP-1039 in Subjects With Endometrial Cancers

Endometrial Cancers With FGFR2 Mutations
Foresee Pharmaceuticals Co., Ltd.

Terminated

A Phase 2/3 Study to Evaluate FP-025 in Patients With Severe to Critical COVID 19

Severe to Critical COVID 19 With Associated ARDS

United States
Immune Targeting Systems Ltd
INCResearch Australia Pty Limited

Completed

Safety, Tolerability and Immunogenicity of Two Different Formulations of an Influenza A Vaccine (FP-01.1)

Influenza A

Australia
Foresee Pharmaceuticals Co., Ltd.
InClin, Inc.

Not yet recruiting

Safety, Tolerability, and Pharmacokinetics, of Single and Multiple Ascending Doses of FP-020 in Healthy Adult Volunteers

Healthy

Australia
National University Health System, Singapore

Active, not recruiting

Artificial Intelligence in Categorizing the Severity of Oxygenation by Incorporating the PEEP Into the Definition of ARDS in Ventilated Patients (P/FP ratio)

ARDS

Singapore
Foresee Pharmaceuticals Co., Ltd.

Completed

Multiple-Dose, Dose-Escalation Study to Evaluate the Safety/Tolerability and Pharmacokinetics of FP-045

Healthy Volunteers

Australia
Foresee Pharmaceuticals Co., Ltd.
QPS-Qualitix

Completed

Phase 1 Safety, Tolerability and Pharmacokinetics (PK) Study of FP-025 in Healthy Volunteers

Healthy

Taiwan
National University Health System, Singapore

Completed

PaO2/FiO2*PEEP (P/FP) Ratio and Mortality in Acute Respiratory Distress Syndrome.

Adult Respiratory Distress Syndrome

Singapore
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics

Asthma

Germany
Foresee Pharmaceuticals Co., Ltd.

Completed

A Phase 1, Pharmacokinetics of the MMP-12 Inhibitor FP-025 After Multiple Oral Ascending Doses in Healthy Subjects

Healthy

Netherlands
Fervent Pharmaceuticals
Iqvia Pty Ltd

Completed

FP-101 for the Treatment of Hot Flashes in Postmenopausal Women

Hot Flashes

United States
BeBetter Med Inc
Xiangya Hospital of Central South University

Recruiting

Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation

Advanced or Metastatic Solid Tumor | KRAS G12C Mutation

China
Leena Nahata
National Cancer Institute (NCI)

Enrolling by invitation

Fertility Preservation in Male AYA With Cancer

Infertility, Male

United States
Texas Tech University
Alliance for Potato Research and Education

Active, not recruiting

Effects of Potatoes on Blood Pressure in Persons With and Without Type 2 Diabetes Who Follow the DASH Diet for 6 Weeks

Type 2 Diabetes | Blood Pressure

United States
GlaxoSmithKline

Completed

GSK BHR Study (Sont - Second Study)

Asthma

United States, Bulgaria, Puerto Rico, Brazil
GlaxoSmithKline

Completed

GSK BHR Study (Sont)

Asthma

United States, Latvia, Puerto Rico, Brazil
United States Army Research Institute of Environmental...
Walter Reed Army Institute of Research (WRAIR); University of Reading; US Army...

Completed

Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude

Acute Mountain Sickness | Gastrointestinal Injury

United States
London School of Hygiene and Tropical Medicine
Bill and Melinda Gates Foundation; Population Council; International Planned...

Completed

Benefits and Costs of Integrating Sexual-Reproductive Health and HIV Services in Kenya and Swaziland (Integra)

Pregnancy | HIV

Kenya, Swaziland
Faron Pharmaceuticals Ltd

Completed

A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)

Cancer

Finland, United Kingdom, Netherlands, United States, France, Spain
Universidade Estadual de Goiás
University of Brasilia

Completed

Kinesio Taping Effects Applied With Different Directions and Tensions

MYOSITIS
Population Health Research Institute

Recruiting

Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients (FARGO)

Gynecologic Cancer | Frailty | Oncology

Canada
Immune Targeting Systems Ltd
Hammersmith Medicines Research

Completed

A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine

Influenza

United Kingdom
Chang Gung Memorial Hospital

Unknown

Targeting Monoaminergic Neuronal Networks in the Parkinsonian Patients After Carbon Monoxide Intoxication

Carbon Monoxide-induced Parkinsonism

Taiwan
Baskent University

Completed

Effects of Kinesio Taping on Postural Stability in Young Soccer Players

Increasing Performance of Healthy Athlete

Turkey
National Institute of Mental Health (NIMH)

Completed

Brain Imaging in Elderly People and Individuals With Alzheimer's Disease

Healthy | Alzheimer's Disease

United States
Assistance Publique - Hôpitaux de Paris
Association Française contre les Myopathies (AFM), Paris; ARS (Association... and other collaborators

Completed

Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls (DOSERAL)

Amyotrophic Lateral Sclerosis

France
National Institute of Neurological Disorders and...

Completed

Cholinergic Receptor Imaging in Dystonia

Cervical Dystonia | Dystonia | Focal Dystonia | Movement Disorder

United States
The University of Texas Health Science Center at...
Faron Pharmaceuticals Ltd

Withdrawn

Dose Escalation Trial of Bexmarilimab (FP-1305) Plus Pembrolizumab in Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
GlaxoSmithKline

Completed

A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo

Dermatitis, Atopic

Germany
CSL Behring

Completed

A Safety and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor VIIa With Albumin (rVIIa-FP) in Healthy Male Volunteers

Healthy

Germany
Hamamatsu University
Oita University

Unknown

The Influence of FP-10 on the Eradication Rates of H. Pylori by a Triple Therapy

Helicobacter Pylori

Japan
Stanford University
Pliant Therapeutics, Inc.

Recruiting

Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT

Idiopathic Pulmonary Fibrosis | Primary Sclerosing Cholangitis | Covid19 Pneumonia

United States
GlaxoSmithKline

Completed

Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma

Asthma

Japan
University of Texas at Austin
Baylor College of Medicine

Recruiting

Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression (TBF)

Fall | Depression, Unipolar

United States
The University of Texas at San Antonio
American Diabetes Association

Unknown

Building a Healthy Temple: a Diabetes Self-management Support Program in Hispanic Faith Community Settings

Type2 Diabetes Mellitus

United States
Ministry of Health, Labour and Welfare, Japan

Unknown

Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC

Neoplasms | Carcinoma | Carcinoma, Hepatocellular | Liver Neoplasms | Advanced Hepatocellular Carcinoma

Japan
Population Council
Bill and Melinda Gates Foundation

Recruiting

Pilot Study on Engaging Family Physicians in Family Planning in Pakistan (FPFP)

Contraception | Contraceptive Usage

Pakistan
Altimmune, Inc.

Completed

Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B

Hepatitis B

Korea, Republic of, United Kingdom
Pusan National University Hospital

Completed

Prediction of Future Weight Change With Dopamine Transporter

Weight Change, Body
Immune Targeting Systems Ltd

Completed

Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge

Influenza A

United Kingdom

Search clinical trials for: FP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations